After spectacular fundraising success during the pandemic followed by a spectacular crash when ideas failed to bear fruit, investors are starting to return to the more promising parts of the listed biotech sector.
在大流行期间获得了惊人的融资成功，之后又因想法未能结出果实而遭遇了惊人的崩盘，投资者正开始回归上市生物科技行业中更有前景的部分。
您已阅读2%（278字），剩余98%（11274字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。